Orchestra BioMed Holdings, Inc. Ratios

Ratios Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 94.03%93.26%92.27%
EBT Margin -924.34%-1,726.70%-2,310.27%
EBIT Margin -924.34%-1,866.16%-2,437.49%
EBITDA Margin -951.49%-1,779.78%-2,310.92%
Operating Margin -924.34%-1,866.16%-2,437.49%
Net Margin -924.34%-1,726.70%-2,310.27%
FCF Margin -845.74%-1,674.09%-1,927.48%
Efficiency
Inventory Average 0.21M0.16M
Assets Average 95.39M85.69M
Equity Average 60.29M50.50M
Invested Capital 54.62M68.04M32.96M
Asset Utilization Ratio 0.030.03
Leverage & Solvency
Debt to Equity 0.220.43
Debt Ratio 0.120.19
Equity Ratio 0.550.710.43
Valuation
Enterprise Value 159.23M184.75M50.70M
Market Capitalization 305.71M326.34M152.05M
Return Ratios
Return on Sales -9.24%-17.27%-23.10%
Return on Capital Employed -0.61%-0.93%
Return on Assets -0.50%-0.71%
Return on Equity -0.79%-1.21%